Center for Financial Planning’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318 Hold
20
﹤0.01% 625
2025
Q4
$526 Hold
20
﹤0.01% 650
2025
Q3
$452 Hold
20
﹤0.01% 629
2025
Q2
$398 Hold
20
﹤0.01% 616
2025
Q1
$338 Hold
20
﹤0.01% 675
2024
Q4
$370 Hold
20
﹤0.01% 641
2024
Q3
$435 Hold
20
﹤0.01% 542
2024
Q2
$393 Hold
20
﹤0.01% 555
2024
Q1
$434 Hold
20
﹤0.01% 583
2023
Q4
$579 Hold
20
﹤0.01% 501
2023
Q3
$535 Hold
20
﹤0.01% 494
2023
Q2
$741 Hold
20
﹤0.01% 531
2023
Q1
$625 Hold
20
﹤0.01% 495
2022
Q4
$596 Hold
20
﹤0.01% 499
2022
Q3
$1K Hold
20
﹤0.01% 592
2022
Q2
$1K Hold
20
﹤0.01% 498
2022
Q1
$1K Hold
20
﹤0.01% 500
2021
Q4
$2K Hold
20
﹤0.01% 480
2021
Q3
$2K Hold
20
﹤0.01% 454
2021
Q2
$2K Hold
20
﹤0.01% 458
2021
Q1
$2K Buy
+20
New +$2.06K ﹤0.01% 490

Other funds holding FLGT

Center for Financial Planning's FLGT Position: Q1 2026 in Review

Center for Financial Planning held its Fulgent Genetics (FLGT) position steady in Q1 2026 at 20 shares worth $318. The position accounts for ﹤0.01% of the portfolio, ranked #625.

Center for Financial Planning first reported a position in FLGT in Q1 2021 and has held it in 21 quarters since. The position peaked at $2K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Center for Financial Planning held 20 shares of Fulgent Genetics worth $318 as of Q1 2026.
  • Center for Financial Planning left its Fulgent Genetics share count unchanged in Q1 2026.
  • Fulgent Genetics made up ﹤0.01% of Center for Financial Planning's portfolio in Q1 2026, its #625 holding.
  • Center for Financial Planning first reported a position in Fulgent Genetics in Q1 2021 and has held it in 21 quarters since.
  • Center for Financial Planning's Fulgent Genetics position peaked at $2K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Center for Financial Planning's 13F filing for Q1 2026, filed 4 May 2026.